iSage Rx Presents Positive Clinical Outcomes from Initial Study
10 juin 2019 09h00 HE
|
Amalgam Rx
SAN FRANCISCO, June 10, 2019 (GLOBE NEWSWIRE) -- iSage Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, shared findings from its clinical trial during the poster...
White-Labeled Version of iSage Rx launched in Brazil in collaboration with Novo Nordisk
03 juin 2019 09h00 HE
|
Amalgam Rx
WILMINGTON, Del., June 03, 2019 (GLOBE NEWSWIRE) -- iSage Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, is announcing a collaboration with Novo Nordisk to launch a...
Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization
11 juin 2018 09h00 HE
|
Amalgam Rx
Insulin-Dependent Patients Will Be Enrolled in Clinical Trial Using iSage’s FDA Cleared Insulin Titration Application WILMINGTON, Del., June 11, 2018 (GLOBE NEWSWIRE) -- The University of Kansas...
Amalgam Rx Partners with UCB on BEYOND™, a Digital Health Solution for Patients with Psoriasis and Psoriatic Arthritis
13 déc. 2017 08h00 HE
|
Amalgam Rx
WILMINGTON, Del., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Allay Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, announced today a partnership on a comprehensive behavioral...
Amalgam Rx Unveils iSage Rx, the First FDA-Cleared Application for Titration of all Brands of Basal Insulin
01 mai 2017 08h00 HE
|
Amalgam Rx
WILMINGTON, DE--(Marketwired - May 1, 2017) - Amalgam Rx, a new digital health company, today released iSage Rx, the first FDA 510(k)-cleared, prescription-only mobile application for the automated...
Digital Health Pioneers Launch New Company, Amalgam Rx, to Transform Patient Self-Management and Healthcare Provider Care Delivery
01 mai 2017 08h00 HE
|
Amalgam Rx
WILMINGTON, DE--(Marketwired - May 1, 2017) - Amalgam Rx, Inc., a digital health company, launched today to develop next-generation, evidence-based digital therapies that empower and engage...